Intelligent Bio Solutions Inc.
Healthcare sector | Medical Devices industry
Metrics for INBS
| Price | $2.87 |
|---|---|
| Shares Outstanding | 2.0M |
| All-Time Low | $4.03 |
| 52-Week Low | $4.03 |
Balance Statement Metrics
| Net Cash / Share | $0 |
|---|---|
| Net Current Assets / Share | $2.7 |
| Net Tangible Assets / Share | $3.81 |
| Shares Outstanding Ave Change (Annual) | 390.54% |
| Shares Δ YoY | 111.91% |
| Avg CA Burn (Annual %) | 1.66% (as of 2-23-2026) |
| Avg CA Burn (Quarterly %) | 46.66% (as of 2-23-2026) |
Earning Metrics
| Max Earning Power / Share | $-11.18 |
|---|---|
| Adjusted Earning Power |
$-12.74
adjustedEarningPower = (Net Income / EP_MULTIPLIER) / Shares Outstanding
|
| Non-Cash Charges to Market Cap |
4.91%
nonCashChargeToMKTCAP = Non-Cash Charges / Market Capitalization
|
| Avg EBITDA (5Y) | 0 (as of 2-23-2026) |
| Avg EBITDA (5Q) | 0 (as of 2-23-2026) |
| Avg Net Income (5Y) | -9.9M (as of 2-23-2026) |
| Avg Net Income (5Q) | -2.7M (as of 2-23-2026) |
Indicators
| Dividend indicators | Value | Date |
|---|---|---|
| Current Dividend Streak | No | 2-23-2026 |
| Consecutive Years Paid | No | 2-23-2026 |
| Pays Dividend | No | 2-23-2026 |
| Income indicators | Value | Date |
|---|---|---|
| EBITDA Positive | No | 2-23-2026 |
| Net Income Positive | No | 2-23-2026 |
| Current Dividend Streak | No | 2-23-2026 |
Metric History Explorer
Pick a metric to view its history table and chart.
Tangible Book Value Per Share History
Formula: Tangible Book Value / shares from balance statements. Includes 6 quarterly + 4 annual.
Chart plots one TBV / Share point per report date (duplicate same-date annual/quarterly rows are merged).
| Report Date | Period | TBV / Share | Tangible Book Value | Shares Used |
|---|---|---|---|---|
| 2025-12-31 | Quarterly | $6.32 | 7.8M ($7,823,693) | 1.2M (1,238,434) |
| 2025-09-30 | Quarterly | $0.16 | 147.9K ($147,924) | 909.8K (909,835) |
| 2025-06-30 | Quarterly | $-1.08 | -794.2K ($-794,183) | 732.3K (732,326) |
| 2025-06-30 | Annual | $-1.08 | -794.2K ($-794,183) | 732.3K (732,326) |
| 2025-03-31 | Quarterly | $1.93 | 1.3M ($1,309,626) | 679.4K (679,427) |
| 2024-12-31 | Quarterly | $0.96 | 463.5K ($463,453) | 480.7K (480,695) |
| 2024-09-30 | Quarterly | $3.89 | 1.7M ($1,704,475) | 437.8K (437,764) |
| 2024-06-30 | Annual | $11.45 | 4M ($3,957,324) | 345.6K (345,588) |
| 2023-06-30 | Annual | $-75.04 | -1.5M ($-1,456,417) | 19.4K (19,408) |
| 2022-06-30 | Annual | $1,067.85 | 6.6M ($6,624,922) | 6.2K (6,204) |
Revenue History (Annual)
Revenue from income statements. Includes 4 annual.
Chart plots one annual Revenue point per report date.
| Report Date | Revenue |
|---|---|
| 2025-06-30 | 3.1M ($3,052,532) |
| 2024-06-30 | 3.1M ($3,111,781) |
| 2023-06-30 | 1.3M ($1,256,872) |
| 2022-06-30 | 0 ($0) |
Dividend Payments
Historical cash dividends per share from Yahoo ex-dividend dates.
| Date | Dividend / Share |
|---|---|
| No dividend payment history available yet | |
Shares Outstanding Changes
| Date | Shares Outstanding | Delta |
|---|---|---|
| 2026-03-30 | 2,001,173 | +397,390 |
| 2026-02-17 | 1,603,783 | +387,652 |
Short Interest Changes
Latest short-interest change: 44,416 shares (2.79% of float) | Days to cover: 0.37
| Date | Short Interest | Delta | Δ % |
|---|---|---|---|
| 2026-03-24 | 44,416 shares | -50,005 | -52.96% |
| 2026-03-12 | 94,421 shares | +60,908 | +181.74% |
| 2026-02-27 | 33,513 shares | -98,324 | -74.58% |
Interesting Volume Days
Volume/ratio use shares outstanding as of the event date (frozen).
| Date | Volume | Shares Outstanding | Volume / Shares | Price |
|---|---|---|---|---|
| 2026-02-25 | 1,074,402 | 1,603,783 | 66.99% | $3.96 |
Intelligent Bio Solutions Inc., a medical technology company, focused on developing and delivering non-invasive testing, and screening solutions in Asia Pacific, the United States, the United Kingdom, and internationally. The company operates intelligent fingerprinting drug screening system, a platform to analyze fingerprint sweat analysis to detect drugs abuse; and biosensor platform. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. Intelligent Bio Solutions Inc. was incorporated in 2016 and is headquartered in New York, New York.